WT1 mutations are secondary events in AML, show varying frequencies and impact on prognosis between genetic subgroups

To investigate frequency and prognostic impact of Wilms tumor 1 ( WT1 ) mutations (mut), we analyzed 3157 unselected acute myeloid leukemia patients for WT1 mut in exons 7 and 9. In total, 188 WT1 mutations were detected (exon 7: n =150, exon 9: n =38); 141 were frameshift, 24 missense, 14 non-sense...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Leukemia 2015-03, Vol.29 (3), p.660-667
Hauptverfasser: Krauth, M-T, Alpermann, T, Bacher, U, Eder, C, Dicker, F, Ulke, M, Kuznia, S, Nadarajah, N, Kern, W, Haferlach, C, Haferlach, T, Schnittger, S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To investigate frequency and prognostic impact of Wilms tumor 1 ( WT1 ) mutations (mut), we analyzed 3157 unselected acute myeloid leukemia patients for WT1 mut in exons 7 and 9. In total, 188 WT1 mutations were detected (exon 7: n =150, exon 9: n =38); 141 were frameshift, 24 missense, 14 non-sense, 7 splice site and 2 indel mutations. In 175/3157 (5.5%) patients, a WT1 mut was found. Higher frequencies were detected in patients with biallelic CEBPA mut (13.6%; P =0.001), followed by t(15;17)/ PML-RARA (11.0%, P =0.004), and FLT3 -ITD (8.5%, P
ISSN:0887-6924
1476-5551
DOI:10.1038/leu.2014.243